Cargando…

A liposomal carbohydrate vaccine, adjuvanted with an NKT cell agonist, induces rapid and enhanced immune responses and antibody class switching

BACKGROUND: Congenital disorders of glycosylation (CDGs) are genetic diseases caused by gene defects in glycan biosynthesis pathways, and there is an increasing number of patients diagnosed with CDGs. Because CDGs show many different clinical symptoms, their accurate clinical diagnosis is challengin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jia, Ji-Xiang, Peng, Sen-Lin, Kalisa, Ndayambaje Yvan, Chao, Qiang, Zhou, Zhifang, Gao, Xiao-Dong, Wang, Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236646/ https://www.ncbi.nlm.nih.gov/pubmed/37264420 http://dx.doi.org/10.1186/s12951-023-01927-x

Ejemplares similares

Enhancement of Mucosal Immunogenicity of Viral Vectored Vaccines by the NKT Cell Agonist Alpha-Galactosylceramide as Adjuvant
por: Singh, Shailbala, et al.
Publicado: (2014)

Type II NKT Cell Agonist, Sulfatide, Is an Effective Adjuvant for Oral Heat-Killed Cholera Vaccines
por: Albutti, Aqel, et al.
Publicado: (2021)

Liposome-based polymer complex as a novel adjuvant: enhancement of specific antibody production and isotype switch
por: Chen, Chia-Hung, et al.
Publicado: (2012)

NKT cell adjuvants in therapeutic vaccines against hematological cancers
por: Mattarollo, Stephen R., et al.
Publicado: (2013)

NNKTT120, an anti-iNKT cell monoclonal antibody, produces rapid and sustained iNKT cell depletion in adults with sickle cell disease
por: Field, Joshua J., et al.
Publicado: (2017)

An In Silico Approach for Modelling T-Helper Polarizing iNKT Cell Agonists
por: De Spiegeleer, Anton, et al.
Publicado: (2014)

Transnuclear mice reveal Peyer's patch iNKT cells that regulate B‐cell class switching to IgG1
por: Clancy‐Thompson, Eleanor, et al.
Publicado: (2019)

Intratumoural administration of an NKT cell agonist with CpG promotes NKT cell infiltration associated with an enhanced antitumour response and abscopal effect
por: Prasit, Kef K, et al.
Publicado: (2022)

Combinational PRR Agonists in Liposomal Adjuvant Enhances Immunogenicity and Protective Efficacy in a Tuberculosis Subunit Vaccine
por: Hao, Ling, et al.
Publicado: (2020)

Processing of Switch Transcripts Is Required for Targeting of Antibody Class Switch Recombination
por: Hein, Katharina, et al.
Publicado: (1998)

Mouse Invariant Monoclonal Antibody NKT14: A Novel Tool to Manipulate iNKT Cell Function In Vivo
por: Scheuplein, Felix, et al.
Publicado: (2015)

Liposomes as Adjuvants and Vaccine Delivery Systems
por: Tretiakova, D. S., et al.
Publicado: (2022)

The μ Switch Region Tandem Repeats Are Important, but Not Required, for Antibody Class Switch Recombination
por: Luby, Thomas M., et al.
Publicado: (2001)

Carbohydrate Immune Adjuvants in Subunit Vaccines
por: Bashiri, Sahra, et al.
Publicado: (2020)

Development of a rapid in vitro pre-screen for distinguishing effective liposome-adjuvant delivery systems
por: Feather, Laura A. J., et al.
Publicado: (2022)

Rad52 competes with Ku70/Ku86 for binding to S-region DSB ends to modulate antibody class-switch DNA recombination
por: Zan, Hong, et al.
Publicado: (2017)

Natural IgM and TLR Agonists Switch Murine Splenic Pan-B to “Regulatory” Cells That Suppress Ischemia-Induced Innate Inflammation via Regulating NKT-1 Cells
por: Lobo, Peter I., et al.
Publicado: (2017)

Fundamental Roles of Chromatin Loop Extrusion in Antibody Class Switching
por: Zhang, Xuefei, et al.
Publicado: (2019)

Estrogen Reverses HDAC Inhibitor-Mediated Repression of Aicda and Class-Switching in Antibody and Autoantibody Responses by Downregulation of miR-26a
por: Casali, Paolo, et al.
Publicado: (2020)

Small Cationic DDA:TDB Liposomes as Protein Vaccine Adjuvants Obviate the Need for TLR Agonists in Inducing Cellular and Humoral Responses
por: Milicic, Anita, et al.
Publicado: (2012)

Amide Analogues of CD1d Agonists Modulate iNKT-Cell-Mediated Cytokine Production
por: Wojno, Justyna, et al.
Publicado: (2012)

NKT10 cells: a novel iNKT cell subset
por: Wingender, Gerhard, et al.
Publicado: (2015)

Synthetic Toll Like Receptor-4 (TLR-4) Agonist Peptides as a Novel Class of Adjuvants
por: Shanmugam, Arulkumaran, et al.
Publicado: (2012)

Liposomal delivery system/adjuvant for tuberculosis vaccine
por: Moradi, Melika, et al.
Publicado: (2023)

The NKT cell TCR repertoire can accommodate structural modifications to the lipid and orientation of the terminal carbohydrate of iGb3
por: Cameron, Garth, et al.
Publicado: (2022)

The Prognostic Impact of NK/NKT Cell Density in Periampullary Adenocarcinoma Differs by Morphological Type and Adjuvant Treatment
por: Lundgren, Sebastian, et al.
Publicado: (2016)

NKT Cells in Sepsis
por: Leung, Briana, et al.
Publicado: (2010)

The location of splenic NKT cells favours their rapid activation by blood-borne antigen
por: Barral, Patricia, et al.
Publicado: (2012)

Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapy
por: TANIGUCHI, Masaru, et al.
Publicado: (2015)

Flexible ordering of antibody class switch and V(D)J joining during B-cell ontogeny
por: Kumar, Satyendra, et al.
Publicado: (2013)

The Transcriptional Repressor Gfi1 Plays a Critical Role in the Development of NKT1- and NKT2-Type iNKT Cells
por: Yasuoka, Toshiaki, et al.
Publicado: (2016)

Synthesis of truncated analogues of the iNKT cell agonist, α-galactosyl ceramide (KRN7000), and their biological evaluation
por: Veerapen, Natacha, et al.
Publicado: (2011)

Antibody response of a particle-inducing, liposome vaccine adjuvant admixed with a Pfs230 fragment
por: Huang, Wei-Chiao, et al.
Publicado: (2020)

Sγ3 switch sequences function in place of endogenous Sγ1 to mediate antibody class switching
por: Zarrin, Ali A., et al.
Publicado: (2008)

Novel potent liposome agonists of triggering receptor expressed on myeloid cells 2 phenocopy antibody treatment in cells
por: Boudesco, Christophe, et al.
Publicado: (2022)

Liposomes used as a vaccine adjuvant-delivery system: From basics to clinical immunization
por: Wang, Ning, et al.
Publicado: (2019)

Natural Killer T (NKT) Cells and Periodontitis: Potential Regulatory Role of NKT10 Cells
por: Melgar-Rodríguez, Samanta, et al.
Publicado: (2021)

Role of NKT Cells during Viral Infection and the Development of NKT Cell-Based Nanovaccines
por: Khan, Masood Alam, et al.
Publicado: (2021)

Licensed liposomal vaccines and adjuvants in the antigen delivery system
por: Krasnopolsky, Yuriy, et al.
Publicado: (2022)

Evolution of class switching
por: Van Epps, Heather L.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_6gjp77sfp0dl1siihfjfqfbvh1